Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) EBITDA (2016 - 2025)

American Healthcare REIT (AHR) has disclosed EBITDA for 10 consecutive years, with $11.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 137.05% year-over-year to $11.8 million, compared with a TTM value of $71.2 million through Dec 2025, up 299.59%, and an annual FY2025 reading of $71.2 million, up 299.59% over the prior year.
  • EBITDA was $11.8 million for Q4 2025 at American Healthcare REIT, down from $55.8 million in the prior quarter.
  • Across five years, EBITDA topped out at $55.8 million in Q3 2025 and bottomed at -$39.2 million in Q4 2022.
  • Average EBITDA over 5 years is -$7.9 million, with a median of -$8.1 million recorded in 2022.
  • The sharpest move saw EBITDA plummeted 772.79% in 2023, then surged 2100.22% in 2025.
  • Year by year, EBITDA stood at -$25.0 million in 2021, then plummeted by 56.89% to -$39.2 million in 2022, then grew by 21.47% to -$30.8 million in 2023, then decreased by 3.51% to -$31.8 million in 2024, then skyrocketed by 137.05% to $11.8 million in 2025.
  • Business Quant data shows EBITDA for AHR at $11.8 million in Q4 2025, $55.8 million in Q3 2025, and $10.3 million in Q2 2025.